Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

Lupin share price fell nearly 2 percent in the early trade on February 11 despite the company received United States Food and Drug Administration (USFDA) approval for nasal spray. At 09:23am ...

Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

Stocks including Eicher Motors, Lupin, MTAR Technologies, Aditya Birla Capital, Nykaa, Bata india, SBFC Finance, Samhi Hotels ...

Lupin: The pharma major received approval from the USFDA for its abbreviated new drug application for Ipratropium Bromide Nasal Solution (Nasal Spray) to market a generic equivalent. The product ...

The Indian stock market is set for an eventful session today, with Gift Nifty opening at 23,485.5 and currently trading 0.06% ...